Monitoring of indoor bioaerosol for the detection of SARS-CoV-2 in different hospital settings.

SARS-CoV-2 aerobiology bioaerosol environmental monitoring environmental prevention

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 18 02 2023
accepted: 29 03 2023
medline: 9 5 2023
pubmed: 8 5 2023
entrez: 8 5 2023
Statut: epublish

Résumé

Spore Trap is an environmental detection technology, already used in the field of allergology to monitor the presence and composition of potentially inspirable airborne micronic bioparticulate. This device is potentially suitable for environmental monitoring of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in hospital, as well as in other high-risk closed environments. The aim of the present study is to investigate the accuracy of the Spore Trap system in detecting SARS-CoV-2 in indoor bioaerosol of hospital rooms. The Spore Trap was placed in hospital rooms hosting patients with documented SARS-CoV-2 infection ( The estimated sensitivity of the Spore Trap device for detecting SARS-CoV-2 in an indoor environment is 69.4% (95% C.I. 54.3-84.4%), with a specificity of 100%. The Spore Trap technology is effective in detecting airborne SARS-CoV-2 virus with excellent specificity and high sensitivity, when compared to previous reports. The SARS-CoV-2 pandemic scenario has suggested that indoor air quality control will be a priority in future public health management and will certainly need to include an environmental bio-investigation protocol.

Sections du résumé

Background
Spore Trap is an environmental detection technology, already used in the field of allergology to monitor the presence and composition of potentially inspirable airborne micronic bioparticulate. This device is potentially suitable for environmental monitoring of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in hospital, as well as in other high-risk closed environments. The aim of the present study is to investigate the accuracy of the Spore Trap system in detecting SARS-CoV-2 in indoor bioaerosol of hospital rooms.
Methods
The Spore Trap was placed in hospital rooms hosting patients with documented SARS-CoV-2 infection (
Results
The estimated sensitivity of the Spore Trap device for detecting SARS-CoV-2 in an indoor environment is 69.4% (95% C.I. 54.3-84.4%), with a specificity of 100%.
Conclusion
The Spore Trap technology is effective in detecting airborne SARS-CoV-2 virus with excellent specificity and high sensitivity, when compared to previous reports. The SARS-CoV-2 pandemic scenario has suggested that indoor air quality control will be a priority in future public health management and will certainly need to include an environmental bio-investigation protocol.

Identifiants

pubmed: 37151587
doi: 10.3389/fpubh.2023.1169073
pmc: PMC10157290
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1169073

Informations de copyright

Copyright © 2023 Tedeschini, Pasqualini, Emiliani, Marini, Valecchi, Laoreti, Ministrini, Camilloni, Castronari, Patoia, Merante, Baglioni, De Robertis, Pirro, Mencacci and Pasqualini.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Environ Sci Pollut Res Int. 2022 Feb;29(10):13905-13916
pubmed: 34599449
Int J Infect Dis. 2020 Nov;100:476-482
pubmed: 32949774
Appl Environ Microbiol. 2018 Nov 15;84(23):
pubmed: 30217848
Clin Infect Dis. 2021 Oct 5;73(7):e1870-e1877
pubmed: 32634826
Nat Commun. 2020 May 29;11(1):2800
pubmed: 32472043
Environ Sci Pollut Res Int. 2021 Aug;28(30):40460-40473
pubmed: 33630259
J Appl Microbiol. 2019 Dec;127(6):1596-1611
pubmed: 30974505
J Infect. 2011 Jan;62(1):1-13
pubmed: 21094184
Nature. 2020 Jun;582(7813):557-560
pubmed: 32340022
Appl Environ Microbiol. 2017 Jun 16;83(13):
pubmed: 28455334
Nat Prod Res. 2023 Mar;37(6):974-980
pubmed: 35758279
Clin Transl Allergy. 2018 Apr 04;8:9
pubmed: 29636895
Aerosol Air Qual Res. 2020 Jun;20(6):1167-1171
pubmed: 33424954
J Infect Dis. 2020 Nov 9;222(11):1798-1806
pubmed: 32905595
BMC Public Health. 2012 Aug 02;12:594
pubmed: 22853006
Clin Exp Allergy. 2007 Jan;37(1):125-32
pubmed: 17210050
Indoor Air. 2021 Mar;31(2):314-323
pubmed: 32979298
Ecol Evol. 2018 Mar 25;8(8):3996-4010
pubmed: 29721274

Auteurs

Emma Tedeschini (E)

Dipartimento di Scienze Agrarie, Alimentari e Ambientali, Università degli Studi di Perugia, Perugia, Italy.

Stefania Pasqualini (S)

Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.

Carla Emiliani (C)

Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.

Ettore Marini (E)

Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.

Alessandro Valecchi (A)

Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.

Chiara Laoreti (C)

Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.

Stefano Ministrini (S)

Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.

Barbara Camilloni (B)

Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.

Roberto Castronari (R)

Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.

Lucio Patoia (L)

Ospedale S.G. Battista - Azienda Unità Sanitaria Umbria 2, Foligno, Italy.

Francesco Merante (F)

Ospedale S.G. Battista - Azienda Unità Sanitaria Umbria 2, Foligno, Italy.

Stefano Baglioni (S)

S.C. Pneumologia, Ospedale Santa Maria della Misericordia, Azienda Ospedaliera di Perugia, Perugia, Italy.

Edoardo De Robertis (E)

Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.

Matteo Pirro (M)

Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.

Antonella Mencacci (A)

Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.

Leonella Pasqualini (L)

Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH